capmatinib [Supplementary Concept]
a c-Met inhibitor
Date introduced: February 5, 2017
PubMed search builder options
MeSH Unique ID: C000613976
Registry Number: TY34L4F9OZ
Heading Mapped to:
Entry Terms:
- 2-fluoro-N-methyl-4-(7-(quinolin-6-yl-methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide
- 2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide
- INC280
- INCB28060
- INCB-28060 free base
- NVP-INC280
- NVP-INC280-NX
- INC-280
- INCB-28060
- CMC-583
- capmatinib metabolite M13
- CMC583
- 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzoic acid
- CNJ-294
- 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)-(1,2,4)triazin-2-yl)benzamide
- capmatinib metabolite M18
- CNJ294
- capmatinib dihydrochloride
- 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide dihydrochloride
- capmatinib hydrochloride anhydrous
- capmatinib dihydrochloride monohydrate
- capmatinib hydrochloride
- 2-fluoro-n-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2- b)(1,2,4)triazin-2-yl)benzamide dihydrochloride monohydrate
- Tabrecta